To determine the immediate pain-relieving effect of photobiomodulation therapy (PBMt) in patients with oral ulcers of chronic graft-versus-host disease (cGVHD) refractory to first line therapy with topical corticosteroids.
This retrospective study included all patients who underwent PBMt for pain relief of refractory oral cGVHD lesions. PBMt was applied using an intraoral approach to all sites with mucosal lesions, using a 940 nm InGaAsP diode laser device, with the following parameters: pulsed modulation (duty cycle of 50%), power 0.7 W, illuminated spot size 7.1 cm2, irradiance 98.6 mW/cm2, and irradiation time 90 s per point. Pain was self-assessed using a 0-to-10 scale immediately before and after PBMt.
Data from eleven patients with a total of 56 PBMt sessions were analyzed. In 48 (85.7%) sessions, the patients reported less pain immediately after treatment, with a reduction of ≥ 50% of the initial pain level in 43 (76.8%) sessions. Mean pre- and post-treatment pain levels were 5.20 ±2.7 and 1.38 ±2.1, respectively (p < 0.001), i.e., a post-treatment reduction of 73.4% of the initial pain level. The benefits of the treatment remained for a mean of 6.50 ±5.4 days (range of 2 to 14 days). No adverse effects were reported.
PBMt seems to be a promising treatment modality for refractory oral cGVHD lesions as a rapid pain reliever with relatively long-lasting effects.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
N/A (all the relevant data is provided in the article).
Elad S, Aljitawi O, Zadik Y (2020) Oral graft-versus-host disease: a pictorial review and a guide for dental practitioners. Int Dent J. In press. https://doi.org/10.1111/idj.12584
Elad S, Zadik Y, Caton JG, Epstein JB (2019) Oral mucosal changes associated with primary diseases in other body systems. Periodontol 2000 80(1):28–48. https://doi.org/10.1111/prd.12265
Elad S, Zadik Y, Zeevi I, Miyazaki A, de Figueiredo MA, Or R (2010) Oral cancer in patients after hematopoietic stem-cell transplantation: long-term follow-up suggests an increased risk for recurrence. Transplantation. 90(11):1243–1244. https://doi.org/10.1097/TP.0b013e3181f9caaa
Bar O, Elad S, Avni B, Abu-Tair J, Zaharia B, Hanut A, Zadik Y (2021) Oral verruciform xanthoma in chronic graft-versus-host disease patients. Support Care Cancer. 29(1):79–84. https://doi.org/10.1007/s00520-020-05681-w
Kuten-Shorrer M, Woo SB, Treister NS (2014) Oral graft-versus-host disease. Dent Clin North Am. 58(2):351–368. https://doi.org/10.1016/j.cden.2013.12.007
Zadik Y (2016) Restricted mouth opening in chronic graft-versus-host disease. Oral Surg Oral Med Oral Pathol Oral Radiol. 121(2):201–202. https://doi.org/10.1016/j.oooo.2015.07.041
Elad S, Zadik Y, Yarom N (2017) Oral complications of nonsurgical cancer therapies. Atlas Oral Maxillofac Surg Clin North Am. 25(2):133–147. https://doi.org/10.1016/j.cxom.2017.04.006
Elad S, Jensen SB, Raber-Durlacher JE, Mouradian N, Correa EMP, Schubert MM, Blijlevens NMA, Epstein JB, Saunders DP, Waltimo T, Yarom N, Zadik Y, Brennan MT (2015) Clinical approach in the management of oral chronic graft-versus-host disease (cGVHD) in a series of specialized medical centers. Support Care Cancer. 23(6):1615–1622. https://doi.org/10.1007/s00520-014-2503-x
Zadik Y, Elad S, Shapira A, Shapira MY (2017) Treatment of oral mucosal manifestations of chronic graft-versus-host disease: dexamethasone vs. budesonide. Expert Opin Pharmacother. 18(3):235–242. https://doi.org/10.1080/14656566.2017.1282464
Treister N, Duncan C, Cutler C, Lehmann L (2012) How we treat oral chronic graft-versus-host disease. Blood. 120(17):3407–3418. https://doi.org/10.1182/blood-2012-05-393389
Hui RL, Lide W, Chan J, Schottinger J, Yoshinaga M, Millares M (2009) Association between exposure to topical tacrolimus or pimecrolimus and cancers. Ann Pharmacother. 43(12):1956–1963. https://doi.org/10.1345/aph.1M278
Cai SC, Li W, Tian EA, Allen JC, Tey HL (2016) Topical calcineurin inhibitors in eczema and cancer association: a cohort study. J Dermatolog Treat. 27(6):531–537. https://doi.org/10.3109/09546634.2016.1163317
Zadik Y (2020) Pharmacotherapy of oral mucosal manifestations of chronic graft-versus-host disease: when? what? and how? Expert Opin Pharmacother. 21(12):1389–1392. https://doi.org/10.1080/14656566.2020.1763307
Epstein JB, Raber-Durlacher JE, Lill M, Linhares YPL, Chang J, Barasch A, Slief RIC, Geuke M, Zecha JAEM, Milstein DMJ, Tzachanis D (2017) Photobiomodulation therapy in the management of chronic oral graft-versus-host disease. Support Care Cancer. 25(2):357–364. https://doi.org/10.1007/s00520-016-3401-1
Epstein JB, Raber-Durlacher JE, Epstein GL, Hazenberg MD, Tzachanis D, Spielberger RT (2020) Chronic oral graft-versus-host disease: induction and maintenance therapy with photobiomodulation therapy. Support Care Cancer. In press. https://doi.org/10.1007/s00520-020-05626-3
Arany PR (2016) Craniofacial wound healing with photobiomodulation therapy: new insights and current challenges. J Dent Res. 95(9):977–984. https://doi.org/10.1177/0022034516648939
Gavish L, Houreld NN (2019) Therapeutic efficacy of home-use photobiomodulation devices: a systematic literature review. Photobiomodul Photomed Laser Surg. 37(1):4–16. https://doi.org/10.1089/photob.2018.4512
Dillenburg CS, Martins MA, Munerato MC, Marques MM, Carrard VC, Sant'Ana Filho M, Castilho RM, Martins MD (2014) Efficacy of laser phototherapy in comparison to topical clobetasol for the treatment of oral lichen planus: a randomized controlled trial. J Biomed Opt. 19(6):068002. https://doi.org/10.1117/1.JBO.19.6.068002
Jajarm HH, Falaki F, Mahdavi O (2011) A comparative pilot study of low intensity laser versus topical corticosteroids in the treatment of erosive-atrophic oral lichen planus. Photomed Laser Surg. 29(6):421–425. https://doi.org/10.1089/pho.2010.2876
El Shenawy HM, Eldin AM (2015) A comparative evaluation of low-level laser and topical steroid therapies for the treatment of erosive-atrophic lichen planus. Open Access Maced J Med Sci. 3(3):462–466. https://doi.org/10.3889/oamjms.2015.072
Al-Maweri SA, Kalakonda B, Al-Soneidar WA, Al-Shamiri HM, Alakhali MS, Alaizari N (2017) Efficacy of low-level laser therapy in management of symptomatic oral lichen planus: a systematic review. Lasers Med Sci. 32(6):1429–1437. https://doi.org/10.1007/s10103-017-2233-7
Akram Z, Abduljabbar T, Vohra F, Javed F (2018) Efficacy of low-level laser therapy compared to steroid therapy in the treatment of oral lichen planus: a systematic review. J Oral Pathol Med. 47(1):11–17. https://doi.org/10.1111/jop.12619
Chow R, Armati P, Laakso EL, Bjordal JM, Baxter GD (2011) Inhibitory effects of laser irradiation on peripheral mammalian nerves and relevance to analgesic effects: a systematic review. Photomed Laser Surg. 29(6):365–381. https://doi.org/10.1089/pho.2010.2928
Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Sonis ST, Elad S, Hamblin MR, Barasch A, Migliorati CA, Milstein DM, Genot MT, Lansaat L, van der Brink R, Arnabat-Dominguez J, van der Molen L, Jacobi I, van Diessen J, de Lange J, Smeele LE, Schubert MM, Bensadoun RJ (2016) Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 24(6):2781–2792. https://doi.org/10.1007/s00520-016-3152-z
Zadik Y (2019) Photobiomodulation for the palliation of oral mucositis in cancer patients: the future is here. Future Oncol. 15(32):3647–3649. https://doi.org/10.2217/fon-2019-0461
Treister NS, London WB, Guo D, Malsch M, Verrill K, Brewer J, Margossian S, Duncan C (2016) A feasibility study evaluating extraoral photobiomodulation therapy for prevention of mucositis in pediatric hematopoietic cell transplantation. Photomed Laser Surg. 34(4):178–184. https://doi.org/10.1089/pho.2015.4021
Zadik Y, Arany PR, Fregnani ER et al (2019) Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 27(10):3969–3983. https://doi.org/10.1007/s00520-019-04890-2
Ottaviani G, Gobbo M, Sturnega M, Martinelli V, Mano M, Zanconati F, Bussani R, Perinetti G, Long CS, di Lenarda R, Giacca M, Biasotto M, Zacchigna S (2013) Effect of class IV laser therapy on chemotherapy-induced oral mucositis: a clinical and experimental study. Am J Pathol. 183(6):1747–1757. https://doi.org/10.1016/j.ajpath.2013.09.003
Sonis ST, Hashemi S, Epstein JB, Nair RG, Raber-Durlacher JE (2016) Could the biological robustness of low level laser therapy (photobiomodulation) impact its use in the management of mucositis in head and neck cancer patients. Oral Oncol. 54:7–14. https://doi.org/10.1016/j.oraloncology.2016.01.005
Antunes HS, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, de Assis Ramos G, Dias FL, Ferreira CG (2017) Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis. Oral Oncol. 71:11–15. https://doi.org/10.1016/j.oraloncology.2017.05.018
Brandão TB, Morais-Faria K, Ribeiro ACP, Rivera C, Salvajoli JV, Lopes MA, Epstein JB, Arany PR, de Castro G Jr, Migliorati CA, Santos-Silva AR (2018) Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses. Support Care Cancer. 26(7):2417–2423. https://doi.org/10.1007/s00520-018-4046-z
Zecha JA, Raber-Durlacher JE, Nair RG et al (2016) Low-level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 2: proposed applications and treatment protocols. Support Care Cancer. 24(6):2793–2805. https://doi.org/10.1007/s00520-016-3153-y
Heiskanen V, Zadik Y, Elad S (2020) Photobiomodulation therapy for cancer treatment-related salivary gland dysfunction: a systematic review. Photobiomodul Photomed Laser Surg. 38(6):340–347. https://doi.org/10.1089/photob.2019.4767
Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan RM, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V (2020) Bossi P; Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 126(19):4423–4431. https://doi.org/10.1002/cncr.33100
Miranda-Silva W, Gomes-Silva W, Zadik Y, Yarom N, Al-Azri AR, Hong CHL, Ariyawardana A, Saunders DP, Correa ME, Arany PR, Bowen J, Cheng KKF, Tissing WJE, Bossi P, Elad S (2020) MASCC/ISOO clinical practice guidelines for the management of mucositis: sub-analysis of current interventions for the management of oral mucositis in pediatric cancer patients. Support Care Cancer. In press. https://doi.org/10.1007/s00520-020-05803-4
Conflicts of interest
The authors declare that they have no conflict of interest.
The study protocol was approved by the Institutional Review Board (HMO-20-0330).
Consent to participate
The Institutional Review Board determined of exemption from informed consent (because of the retrospective design of the study).
Consent for publication
N/A (there are no personal data and/or images in the article).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Finfter, O., Avni, B., Grisariu, S. et al. Photobiomodulation (low-level laser) therapy for immediate pain relief of persistent oral ulcers in chronic graft-versus-host disease. Support Care Cancer (2021). https://doi.org/10.1007/s00520-021-05997-1
- Allogeneic hematopoietic stem cell transplantation
- Chronic graft-versus-host disease
- Hematopoietic stem cell transplantation
- Low-level laser
- Oral complications
- Oral medicine